Is serotonin pathology a good biomarker in vivo for early Parkinson's disease?

Ann Transl Med. 2019 Dec;7(Suppl 8):S351. doi: 10.21037/atm.2019.09.80.

Celia Painous^{1

2

3

4}, Andres Perissinotti⁵, Maria J Martí^{1

2

3

4}

¹ Parkinson's Disease & Movement Disorders Unit, Hospital Clínic Barcelona, Barcelona, Spain.
² DIBAPS-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
³ Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
⁴ Universitat de Barcelona, Catalonia, Spain.
⁵ Nuclear Medicine Department, Hospital Clínic Barcelona & Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain.

No abstract available

Publication types